Akero Therapeutics Inc (AKRO)
19.74
+0.81
(+4.28%)
USD |
NASDAQ |
Apr 26, 16:00
19.72
-0.02
(-0.13%)
After-Hours: 20:00
Akero Therapeutics Market Cap: 1.361B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 1.361B |
| April 25, 2024 | 1.305B |
| April 24, 2024 | 1.397B |
| April 23, 2024 | 1.448B |
| April 22, 2024 | 1.433B |
| April 19, 2024 | 1.431B |
| April 18, 2024 | 1.414B |
| April 17, 2024 | 1.489B |
| April 16, 2024 | 1.502B |
| April 15, 2024 | 1.498B |
| April 12, 2024 | 1.529B |
| April 11, 2024 | 1.506B |
| April 10, 2024 | 1.510B |
| April 09, 2024 | 1.637B |
| April 08, 2024 | 1.595B |
| April 05, 2024 | 1.601B |
| April 04, 2024 | 1.584B |
| April 03, 2024 | 1.598B |
| April 02, 2024 | 1.612B |
| April 01, 2024 | 1.660B |
| March 28, 2024 | 1.742B |
| March 27, 2024 | 1.686B |
| March 26, 2024 | 1.682B |
| March 25, 2024 | 1.666B |
| March 22, 2024 | 1.733B |
| Date | Value |
|---|---|
| March 21, 2024 | 1.788B |
| March 20, 2024 | 1.737B |
| March 19, 2024 | 1.782B |
| March 18, 2024 | 1.851B |
| March 15, 2024 | 1.899B |
| March 14, 2024 | 1.887B |
| March 13, 2024 | 1.928B |
| March 12, 2024 | 1.962B |
| March 11, 2024 | 2.021B |
| March 08, 2024 | 2.150B |
| March 07, 2024 | 1.738B |
| March 06, 2024 | 1.689B |
| March 05, 2024 | 1.718B |
| March 04, 2024 | 1.749B |
| March 01, 2024 | 1.566B |
| February 29, 2024 | 1.519B |
| February 28, 2024 | 1.533B |
| February 27, 2024 | 1.537B |
| February 26, 2024 | 1.346B |
| February 23, 2024 | 1.427B |
| February 22, 2024 | 1.350B |
| February 21, 2024 | 1.340B |
| February 20, 2024 | 1.205B |
| February 16, 2024 | 1.165B |
| February 15, 2024 | 1.194B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
280.18M
Minimum
Jun 01 2022
3.147B
Maximum
Jun 13 2023
1.129B
Average
910.51M
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals Inc | 3.847B |
| 89bio Inc | 786.56M |
| Viking Therapeutics Inc | 8.194B |
| Eli Lilly and Co | 697.40B |
| Ionis Pharmaceuticals Inc | 6.062B |
Market Cap Related Metrics
| Price to Book Value | 2.542 |
| Price | 19.74 |
| Earnings Yield | -14.59% |